Skip to main content
SpringerLink
Log in

Taxol in metastatic breast cancer: the MD Anderson Cancer Center experience

  • Conference paper
Book cover Cancer Treatment An Update

  • 73 Accesses

Abstract

We have performed three studies with taxol in metastatic breast cancer: a phase II trial in patients who had received only one prior chemotherapy regimen [1], an ongoing phase I trial of taxol with a fixed dose of Doxorubicin [2, 3], and an ongoing phase II trial in patients with either two or three or more chemotherapy regimens.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Holmes FA, Walters RS, Theriault RL et al (1991) Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer. J Natl Cancer Inst 83: 1797–1805

    Article  PubMed  CAS  Google Scholar 

  2. Holmes FA, Frye D, Valero V et al (1992) Phase I study of taxol and Doxorubicin with G-CSF in patients without prior chemotherapy for metastatic breast cancer (Abstr 66). Proc Am Soc Clin Oncol 11: 60

    Google Scholar 

  3. Holmes FA, Valero V, Walters RS et al (1992) The MD Anderson Cancer Center experience with taxol in metastatic breast cancer. Proceedings of the Second National Cancer Institute Workshop on Taxol and the Taxanes, Arlington, VA, September 23–24, 1992

    Google Scholar 

  4. Hayward JL, Rubens RD, Carbone PP et al (1977) Assessment of response to therapy in advanced breast cancer. Br J Cancer 35: 292–298

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  5. Ajani JA, Welch SR, Raber MN et al (1990) Comprehensive criteria for assessing therapy-induced toxicity. Cancer Invest 8: 147–159

    Article  PubMed  CAS  Google Scholar 

  6. Fisherman J, McCabe M, Hillig M et al (1992) Phase I study of taxol and Doxorubicin with G-CSF in previously untreated metastatic breast cancer (Abstr 54). Proc Am Soc Clin Oncol 11: 57

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Breast and Gynecologic Medical Oncology, UTMD Anderson Cancer Center-56, 1515 Holcombe Blvd, Houston, TX, 77030, USA

    F. A. Holmes, V. Valero, R. Walters, R. Theriault, D. Booser, A. Buzdar, H. Gibbs, D. Frye, K. Young & G. Hortobagyi

Authors
  1. F. A. Holmes
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. Valero
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Walters
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. Theriault
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D. Booser
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Buzdar
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. H. Gibbs
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. D. Frye
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. K. Young
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. G. Hortobagyi
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Hôpital Saint-Louis, 1, avenue Vellefaux, 75475, Paris Cedex 10, France

    P. Banzet

  2. The Mount Sinai Medical Center, 1 G. Levy Place, New York, NY, 10029-6574, USA

    J. F. Holland

  3. Service d’Oncologie Médicale, Hôpital Pitié-Salpétrière Pavillon Jacquart, 47, boulevard de l’Hôpital, 75651, Paris Cedex 13, France

    D. Khayat

  4. Hôpital Pitié-Salpétrière Pavillon Jacquart, 47, boulevard de l’Hôpital, 75651, Paris Cedex 13, France

    M. Weil

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer-Verlag France

About this paper

Cite this paper

Holmes, F.A. et al. (1994). Taxol in metastatic breast cancer: the MD Anderson Cancer Center experience. In: Banzet, P., Holland, J.F., Khayat, D., Weil, M. (eds) Cancer Treatment An Update. Springer, Paris. https://doi.org/10.1007/978-2-8178-0765-2_32

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0765-2_32

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-8178-0767-6

  • Online ISBN: 978-2-8178-0765-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation